TABLE 1.
Comparison of clinical characteristics of nosocomial and POA patients
| Isolate | Location | Patient | Source | Fluconazole MIC (µg/ml) | SRA accession no. |
|---|---|---|---|---|---|
| CA01 | NMH | Nosocomial 1 | Pleural fluid | 2 | SRR12363130, SRR12363136 |
| CA02 | NMH | POA1 | Blood | 4 | SRR12363129 |
| CA03 | NMH | POA2 | Urine | 2 | SRR12363163 |
| CA04 | NMH | Nosocomial 2 | Respiratory | 4 | SRR12363162 |
| CA05 | NMH | POA3 | Blood | 2 | SRR12363161 |
| CA06 | NMH | Nosocomial 3 | Blood | 4 | SRR12363160 |
| CA07 | NMH | Nosocomial 4 | Wound | 2 | SRR12363159 |
| CA08 | NMH | POA4 | Patient room | Unknown | SRR12363158 |
| CA09 | NMH | POA4 | Patient room | Unknown | SRR12363157 |
| CA10 | NMH | POA4 | Patient room | Unknown | SRR12363156 |
| CA11 | NMH | POA4 | Urine | 4 | SRR12363155 |
| CA12 | NMH | Nosocomial 5 | Respiratory | 4 | SRR12363154 |
| CA13 | NMH | POA5 | Wound | 2 | SRR12363152 |
| CA14 | NMH | POA6 | Urine | 4 | SRR12363151 |
| CA15 | NMH | POA7 | Skin | 2 | SRR12363150 |
| CA16 | NMH | POA7 | Nose | Unknown | SRR12363149 |
| CA17 | NMH | POA7 | Axilla | Unknown | SRR12363148 |
| CA18 | NMH | POA7 | Groin | Unknown | SRR12363147 |
| CA19 | NMH | POA8 | Skin | 2 | SRR12363146 |
| CA20 | NMH | POA9 | Skin | Unknown | SRR12363145 |
| CA21 | ACL/5.5 milesa | ACL | Respiratory | 4 | SRR12363144 |
| CA22 | ACL/16.4 milesa | ACL | Blood | 2 | SRR12363143 |
| CA23 | ACL/16.4 milesa | ACL | Urine | 4 | SRR12363141 |
| CA24 | ACL/15.2 milesa | ACL | Urine | 256 | SRR12363140 |
| CA25 | ACL/15.2 milesa | ACL | Synovial | 128 | SRR12363139 |
| CA26 | CDC/Venezuela | CDC | AR-0385 | 256 | SRR12363138 |
| CA27 | CDC/Venezuela | CDC | AR-0386 | 256 | SRR12363137 |
a
Miles indicate distance from NMH.